openPR Logo
Press release

Global Neuropsychiatric Drugs Market Assessment 2020 – Key players such as Sage Therapeutics, BlackThorn Therapeutics, H. Lundbeck A/S, Takeda, Cerevel Therapeutics, LLC, etc.

11-20-2020 10:06 AM CET | Health & Medicine

Press release from: InsightAce Analytic Pvt. Ltd.

Global Neuropsychiatric Drugs Market Assessment 2020 – Key

InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on “Global Neuropsychiatric Drugs Market Assessment – Revenue (US$ Mn) Forecast To 2028”

Request for Sample Pages: https://www.insightaceanalytic.com/report-details/global-neuropsychiatric-drugs-market-assessment/

According to the latest research by InsightAce Analytic, the global market for neuropsychiatric drugs is estimated to be valued at US$ XX million in 2020 and is expected to reach US$ XX million by 2028, with a remarkable CAGR of XX% from 2020 to 2028.

Neuropsychiatric disorders encompass a broad range of medical conditions that involve both neurology and psychiatry. Schizophrenia, major depression, and anxiety disorders are the major psychiatric diseases. The neuropsychiatric drug market is a well-established market with the availability of numerous drugs for treating different stages/phases of neuropsychiatric disorders.

The availability of novel therapeutic drugs for neuropsychiatric disease treatment, increased R&D investment by major pharmaceutical companies, and a rising number of individuals suffering from mental disorders are the major growth drivers of the global neuropsychiatric drug market. For instance, neuropsychiatric disorders are among the leading causes of disability in the US, followed by cardiovascular and circulatory diseases and neoplasms (Source: NIH). Around 4.7% of the adult population aged 18 and above regularly feel depressed. Additionally, in January 2020, a clinical-stage biopharmaceutical company BlackThorn Therapeutics focused on evolving targeted drugs for the treatment of central nervous system (CNS) disorders announced the progression of Phase 2 clinical trial for its, BTRX-335140 (BTRX-140), a selective antagonist for the kappa opioid receptor (KOR).

Market players such as Sage Therapeutics, BlackThorn Therapeutics, H. Lundbeck A/S, Takeda, Cerevel Therapeutics, LLC, etc. have various drugs in their pipeline for the treatment of neuropsychiatric disorders. The approval of these drugs in the market during the forecast period is expected to boost market growth significantly in the coming years.

Request for ToC/Proposal: https://www.insightaceanalytic.com/report-details/global-neuropsychiatric-drugs-market-assessment/

The Neuropsychiatric drugs market is fragmented with the presence of various players that operate in drug development for various disease indications and a strong presence in the local as well as international market.

Global neuropsychiatric drugs market report covers prominent players such as Novartis, Otsuka, Allergan, Eli Lilly, Sunovion, AstraZeneca, Actavis Laboratories, Johnson & Johnson, Bristol Myers, Sage Therapeutics, BlackThorn Therapeutics, H. Lundbeck A/S, Takeda, Cerevel Therapeutics, LLC among others.

Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/report-details/global-neuropsychiatric-drugs-market-assessment/

Market Segments
Global Neuropsychiatric Drugs Market Revenue (US$ Mn), By Type, 2018-2028
o Typical Antipsychotics
• Prochlorperazine
• Haloperidol
• Others
o Atypical Antipsychotics
• Aripiprazole
• Asenapine
• Cariprazine
• Clozapine
• Lurasidone
• Olanzapine
• Risperidone
• Others

Global Neuropsychiatric Drugs Market Revenue (US$ Mn), By Indication, 2018-2028
o Schizophrenia
o Bipolar Disorder
o Psychotic Depression
o Others

Global Neuropsychiatric Drugs Market Revenue (US$ Mn), By Route of Administration, 2018-2028
o Oral
o Parenteral

Global Neuropsychiatric Drugs Market Revenue (US$ Mn), By Region, 2018-2028
North America Neuropsychiatric Drugs Market Revenue (US$ Mn), By Country, 2018-2028
o U.S.
o Canada

Europe Neuropsychiatric Drugs Market Revenue (US$ Mn), By Country, 2018-2028
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
o Rest of Europe

Asia Pacific Neuropsychiatric Drugs Market Revenue (US$ Mn), 2018-2028
Latin America Neuropsychiatric Drugs Market Revenue (US$ Mn), 2018-2028
Middle East & Africa Neuropsychiatric Drugs Market Revenue (US$ Mn), 2018-2028

Why should buy this report:
To receive a comprehensive analysis of the growth prospects for the global neuropsychiatric drugs market
To receive industry overview and future trends in the neuropsychiatric drugs market
To analyze the major factors (drivers and restraints) influencing the growth of the neuropsychiatric drugs market
To get information on the neuropsychiatric drugs market size value/revenue (US$ Mn) forecast till 2028
To analyze the competitive developments such as major investments, mergers & acquisition in the neuropsychiatric drugs industry

For More Information @https://www.insightaceanalytic.com/report-details/global-neuropsychiatric-drugs-market-assessment/

InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Neuropsychiatric Drugs Market Assessment 2020 – Key players such as Sage Therapeutics, BlackThorn Therapeutics, H. Lundbeck A/S, Takeda, Cerevel Therapeutics, LLC, etc. here

News-ID: 2191525 • Views:

More Releases from InsightAce Analytic Pvt. Ltd.

Virtualized Evolved Packet Core Market Know the Scope and Trends
Virtualized Evolved Packet Core Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Virtualized Evolved Packet Core Market- (By Offerings (Solutions(Virtualized Packet Gateway, Virtualized Mobility Management Entity (vMME), Policy and Charging Rules Function (PCRF)), Services (Consulting and Advisory Services, System Integration and Deployment Services, Maintenance and Support Services)), Deployment Mode (On-Premises, Cloud-based), By Network Type (LTE, 5G), By End-User (Telecommunication Service Providers, (Mobile Network Operators (MNOs), Virtual Network
Medical Reference Apps Market to Record an Exponential CAGR by 2030
Medical Reference Apps Market to Record an Exponential CAGR by 2030
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Medical Reference Apps Market- by Type (Monthly and Annual Subscriptions), Application (Drug Information, Medical Conditions & Symptoms, Medical News & Development, Articles & Educational Reference Materials, and Other Applications), Types of Platform (Android and iOS), Trends, Industry Competition Analysis, Revenue and Forecast To 2030." Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1031 According to the latest research by InsightAce
AI in Livestock Farming Market 2023 | Detailed Analysis Report to 2030
AI in Livestock Farming Market 2023 | Detailed Analysis Report to 2030
According to the latest research by InsightAce Analytic, the global Artificial Intelligence in Livestock Farming market is expected to register a CAGR of 26.2% during a forecast period of 2022-2030. Download Free Report Brochure: https://www.insightaceanalytic.com/request-sample/1323 AI is just a reflection of human intelligence that employs algorithms to carry out a variety of chores that farmers previously did. Software, apps, and sensors powered by the Internet of Things are the main elements
IoT for Fisheries and Aquaculture Market Exclusive Report to 2030
IoT for Fisheries and Aquaculture Market Exclusive Report to 2030
According to the latest research by InsightAce Analytic, the global IoT for Fisheries and Aquaculture market is valued at US$ 415.37 Million in 2021, and it is expected to reach US$ 1,232.32 Million by 2030, with a CAGR of 13.2% during a forecast period of 2022-2030. Get Free Sample Copy of the Report : https://www.insightaceanalytic.com/request-sample/1303 IoT has already demonstrated a wide range of application sectors in recent years. Internet of Things

All 5 Releases


More Releases for Neuropsychiatric

New Study Offers Detailed Insights on Paediatric Neuropsychiatric Disorders Trea …
Neuropsychiatry is concerned with study of mental disorders of nervous system that arises from overt function of cerebral system. Paediatric neuropsychiatry is a clinical discipline pertaining to the study of diagnosis and treatment of behavioural and psychiatric disorders in infants, children and adolescents. There are several factors which are hampering the functions of nervous system and cerebral function that lead to paediatric neuropsychiatric diseases. Paediatric neuropsychiatric disorders mainly caused due
Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Researchmoz added Most up-to-date research on "Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017" to its huge collection of research reports. Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017 Summary This report provides an overview of the pipeline landscape for neuropsychiatric disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Attention Deficit Hyperactivity Disorder (ADHD), Depression, Schizophrenia, and Tourette syndrome, and features dormant
Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Attention deficit hyperactivity disorder (ADHD) is a group of behavioral symptoms that include inattentiveness, hyperactivity and impulsiveness, with symptoms including disorganized work habits, procrastination and inability to sustain attention on tasks or activities. Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest. Signs and symptoms include sleep disturbances, including insomnia or sleeping too much, changes in appetite, anxiety, agitation or restlessness and physical problems,
Neuropsychiatric Disorders And Treatment Market: Sturdy Expansion CAGR of 6.2% b …
Market Research Future published a research report on “Neuropsychiatric Disorders And Treatment Market Research Report- Global Forecast To 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023. Global Neuropsychiatric Disorders And Treatment Market Research Report, By Disorders (Degenerative Diseases, Neurotic Disorders, Psychosis And Others), By Treatments (Shock Treatment, Drug Treatment, Others) By End Users (Hospitals, Clinics, Research Centers And Others) - Forecast Till 2023 Market Scenario: Neuropsychiatric is the
Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017 | Now A …
Researchmoz added Most up-to-date research on "Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017" to its huge collection of research reports. This report provides an overview of the pipeline landscape for neuropsychiatric disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Attention Deficit Hyperactivity Disorder (ADHD), Depression, Schizophrenia, and Tourette syndrome, and features dormant and discontinued projects. To Get Sample Copy of
Neuropsychiatric Disorder Cluster Drug Development Pipeline Review and Therapeut …
Market Research Hub includes new market research report "Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017" to its huge collection of research reports. This report provides an overview of the pipeline landscape for neuropsychiatric disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Attention Deficit Hyperactivity Disorder (ADHD), Depression, Schizophrenia, and Tourette syndrome, and features dormant and discontinued projects. Request Free Sample